Edwards Lifesciences ( NYSE:EW – Get Rating ) had its price objective increased by equities researchers at Wells Fargo & Company from $78.00 to $90.00 in a research note issued on Thursday, The Fly reports. Wells Fargo & Company ‘s target price would indicate a potential upside of 7.99% from the company's current price. EW has been the subject of a number of other research reports. Mizuho raised their price target on shares of Edwards Lifesciences from $85.00 to $95.00 in a research note on Tuesday.

https://www.dailypolitical.com/2023/04/27/wells-fargo-company-boosts-edwards-lifesciences-nyseew-price-target-to-90-00.html

#dailypolitical